PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics

BACKGROUND: Advanced stage laryngeal squamous cell carcinoma (LSCC) presents a poor prognosis; thus, there is a great need to identify novel prognostic molecular markers. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) is thought to be a novel prognostic factor in several cancers, but its...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Xiaoli, Li, Yunxian, Li, Yixuan, Liu, Wenlin, Lu, Zhongming, Zhan, Jiandong, Xu, Mimi, Chen, Liangsi, Luo, Xiaoning, Cai, Gang, Zhang, Siyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712771/
https://www.ncbi.nlm.nih.gov/pubmed/31455288
http://dx.doi.org/10.1186/s12885-019-6029-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712771/
https://www.ncbi.nlm.nih.gov/pubmed/31455288
http://dx.doi.org/10.1186/s12885-019-6029-y

Ejemplares similares